Korean J Med.  2001 Oct;61(4):439-443.

Cyclophosphamide: Induced lung toxicity in a patient with Wegener's granulomatosis

Affiliations
  • 1Department of Nephrology, School of Medicine, Ajou University, Suwon, Korea.
  • 2Department of Pulmonology & Critical Care Medicine, School of Medicine, Ajou University, Suwon, Korea.
  • 3Department of Diagnostic Radiology, School of Medicine, Ajou University, Suwon, Korea.
  • 4Department of Pathology, School of Medicine, Ajou University, Suwon, Korea.

Abstract

Lung toxicity associated with cyclophosphamide use is a rare but serious side effect, that may result in a fatal course. However no such cases have been reported in Korea, so clinicians would not be alert to this adverse effect. We recently experienced a woman with Wegener's granulomatosis and idiopathic pulmonary fibrosis. This patient had been administered 12 grams of cyclophosphamide for 4 months. At that time of admission, She felt aggravating dyspnea on exertion for 2 weeks. Her chest x-ray and high resolution CT revealed aggravated reticular opacities and ground glass appearances. Dyspnea was improved and ground glass appearances on HRCT was disappeared after discontinuation of cyclophosphamide. We diagnosed this case as cyclophosphamide-induced pneumonitis and report it with a brief review of the literature.

Keyword

Cyclophosphamide; Drug toxicity; Lung

MeSH Terms

Cyclophosphamide*
Drug-Related Side Effects and Adverse Reactions
Dyspnea
Female
Glass
Humans
Idiopathic Pulmonary Fibrosis
Korea
Lung*
Pneumonia
Thorax
Wegener Granulomatosis*
Cyclophosphamide
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr